相关实验视频
Updated: Sep 14, 2025

07:42
Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
18.3K
中央队对阵中央队 周围静脉氧沙利普拉丁的使用和化疗诱导的周围神经病变 严重程度
Tingting Yang1, Yuting Fang2, Lixia Chang1
1Beijing Chaoyang District Sanhuan Cancer Hospital, Beijing, 100122, China.
概括
与外周静脉 (PV) 输注相比,oxaliplatin的中央静脉 (CV) 输注显著减少了化疗诱导的外周神经病变 (CIPN). 这一发现提供了一种简单的策略,可以在特定的患者群体中减轻神经毒性.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 化疗诱导的周围神经病变 (CIPN) 是oxaliplatin的常见剂量限制性毒性.
- 施用氧沙的途径可能会影响CIPN.的发病率和严重程度.
研究的目的:
- 为了比较中央静脉 (CV) 和周围静脉 (PV) 中的CIPN的严重程度,施用氧化.
- 用化学疗法诱导的周围神经病变 (CAS-CIPN) 综合评估量表来评估CV的有效性,以减少与氧沙相关的神经毒性.
主要方法:
- 进行了一项前性观察性队列研究,包括260名接受基于氧沙的化疗的患者.
- 根据输液路线,患者被分为CV (n=60) 和PV (n=200) 组.
- 主要结果是整体CAS-CIPN评分,统计分析包括单变量和多变量逻辑回归,以及子组评估.
主要成果:
- 与PV管理相比,CV管理与相对较低的CAS-CIPN总体得分相关 (p=0.005).
- 多变量分析确定CV给药是对CIPN的保护因素 (OR=0.23,p=0.024).
- 亚组分析显示,中年患者,接受单周期治疗的患者以及肝胆癌和胰腺癌患者的CV治疗显著降低神经毒性.
结论:
- 与外围静脉输液相比,oxaliplatin的中央静脉输液与神经毒性降低有关.
- 简单的,低成本的策略来缓解CIPN,特别是在特定的患者群体中.
相关概念视频
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
316
Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
316
Peripheral Artery Disease IV: Nursing Management
46
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
46
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
264
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
264
Peripheral Artery Disease V: Postoperative Nursing Management
26
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
26
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
324
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
324
Venous Thrombosis IV: Nursing Management
24
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
24

